Publication Information

{'id': 'https://openalex.org/W2395237281', 'doi': 'https://doi.org/10.1080/00498254.2016.1179821', 'title': 'Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects', 'display_name': 'Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects', 'publication_year': 2016, 'publication_date': '2016-05-16', 'ids': {'openalex': 'https://openalex.org/W2395237281', 'doi': 'https://doi.org/10.1080/00498254.2016.1179821', 'mag': '2395237281', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27180975'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/00498254.2016.1179821', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48760969', 'display_name': 'Xenobiotica', 'issn_l': '0049-8254', 'issn': ['0049-8254', '1366-5928'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5110049820', 'display_name': 'Peter N. Morcos', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I129302853', 'display_name': 'Roche (United States)', 'ror': 'https://ror.org/011qkaj49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I118019719', 'https://openalex.org/I129302853']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Peter N. Morcos', 'raw_affiliation_strings': ['Roche Innovation Center, New York, NY, United States,'], 'affiliations': [{'raw_affiliation_string': 'Roche Innovation Center, New York, NY, United States,', 'institution_ids': ['https://openalex.org/I129302853']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100617010', 'display_name': 'Li Yu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I129302853', 'display_name': 'Roche (United States)', 'ror': 'https://ror.org/011qkaj49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I118019719', 'https://openalex.org/I129302853']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Li Yu', 'raw_affiliation_strings': ['Roche Innovation Center, New York, NY, United States,'], 'affiliations': [{'raw_affiliation_string': 'Roche Innovation Center, New York, NY, United States,', 'institution_ids': ['https://openalex.org/I129302853']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005872331', 'display_name': 'Katrijn Bogman', 'orcid': 'https://orcid.org/0000-0003-2191-4461'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Katrijn Bogman', 'raw_affiliation_strings': ['Roche Innovation Center, Basel, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Roche Innovation Center, Basel, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5114128300', 'display_name': 'Mika Sato', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Mika Sato', 'raw_affiliation_strings': ['Chugai Pharmaceuticals, Co. Ltd, Shizuoka, Japan,'], 'affiliations': [{'raw_affiliation_string': 'Chugai Pharmaceuticals, Co. Ltd, Shizuoka, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109870754', 'display_name': 'Hisakazu Katsuki', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hisakazu Katsuki', 'raw_affiliation_strings': ['Chugai Pharmaceutical, Co. Ltd, Tokyo, Japan,'], 'affiliations': [{'raw_affiliation_string': 'Chugai Pharmaceutical, Co. Ltd, Tokyo, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009722979', 'display_name': 'Kosuke Kawashima', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kosuke Kawashima', 'raw_affiliation_strings': ['Chugai Pharmaceuticals, Co. Ltd, Shizuoka, Japan,'], 'affiliations': [{'raw_affiliation_string': 'Chugai Pharmaceuticals, Co. Ltd, Shizuoka, Japan,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102001815', 'display_name': 'David Moore', 'orcid': 'https://orcid.org/0000-0001-9308-5741'}, 'institutions': [{'id': 'https://openalex.org/I129302853', 'display_name': 'Roche (United States)', 'ror': 'https://ror.org/011qkaj49', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I118019719', 'https://openalex.org/I129302853']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David J Moore', 'raw_affiliation_strings': ['Roche Innovation Center, New York, NY, United States,'], 'affiliations': [{'raw_affiliation_string': 'Roche Innovation Center, New York, NY, United States,', 'institution_ids': ['https://openalex.org/I129302853']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087030773', 'display_name': 'Matt Whayman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210113058', 'display_name': 'Roche (United Kingdom)', 'ror': 'https://ror.org/024tgbv41', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I118019719', 'https://openalex.org/I4210113058']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Matt Whayman', 'raw_affiliation_strings': ['Roche Products Ltd, Welwyn, UK, and'], 'affiliations': [{'raw_affiliation_string': 'Roche Products Ltd, Welwyn, UK, and', 'institution_ids': ['https://openalex.org/I4210113058']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021253355', 'display_name': 'Keith Nieforth', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210125531', 'display_name': 'Reckitt Benckiser (United States)', 'ror': 'https://ror.org/030893n97', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210115825', 'https://openalex.org/I4210125531']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Keith Nieforth', 'raw_affiliation_strings': ['d3 Medicine, Parsippany, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'd3 Medicine, Parsippany, NJ, USA', 'institution_ids': ['https://openalex.org/I4210125531']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004205987', 'display_name': 'Katja Heinig', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Katja Heinig', 'raw_affiliation_strings': ['Roche Innovation Center, Basel, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Roche Innovation Center, Basel, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039073041', 'display_name': 'Elena Guerini', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Elena Guerini', 'raw_affiliation_strings': ['Roche Innovation Center, Basel, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Roche Innovation Center, Basel, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055233423', 'display_name': 'Dieter Muri', 'orcid': 'https://orcid.org/0000-0002-7617-9364'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Dieter Muri', 'raw_affiliation_strings': ['Roche Innovation Center, Basel, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Roche Innovation Center, Basel, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013394867', 'display_name': 'Meret Martin‐Facklam', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Meret Martin-Facklam', 'raw_affiliation_strings': ['Roche Innovation Center, Basel, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Roche Innovation Center, Basel, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5028661923', 'display_name': 'Alex Phipps', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210113058', 'display_name': 'Roche (United Kingdom)', 'ror': 'https://ror.org/024tgbv41', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I118019719', 'https://openalex.org/I4210113058']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Alex Phipps', 'raw_affiliation_strings': ['Roche Products Ltd, Welwyn, UK, and'], 'affiliations': [{'raw_affiliation_string': 'Roche Products Ltd, Welwyn, UK, and', 'institution_ids': ['https://openalex.org/I4210113058']}]}], 'institution_assertions': [], 'countries_distinct_count': 4, 'institutions_distinct_count': 4, 'corresponding_author_ids': ['https://openalex.org/A5110049820'], 'corresponding_institution_ids': ['https://openalex.org/I129302853'], 'apc_list': None, 'apc_paid': None, 'fwci': 5.411, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 56, 'citation_normalized_percentile': {'value': 0.999972, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '47', 'issue': '3', 'first_page': '217', 'last_page': '229'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Lung Cancer Research Studies', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/adme', 'display_name': 'ADME', 'score': 0.86870205}, {'id': 'https://openalex.org/keywords/alectinib', 'display_name': 'Alectinib', 'score': 0.49993753}], 'concepts': [{'id': 'https://openalex.org/C69366308', 'wikidata': 'https://www.wikidata.org/wiki/Q2272286', 'display_name': 'ADME', 'level': 3, 'score': 0.86870205}, {'id': 'https://openalex.org/C181389837', 'wikidata': 'https://www.wikidata.org/wiki/Q461809', 'display_name': 'Bioavailability', 'level': 2, 'score': 0.73879164}, {'id': 'https://openalex.org/C10146269', 'wikidata': 'https://www.wikidata.org/wiki/Q185557', 'display_name': 'Excretion', 'level': 2, 'score': 0.66949713}, {'id': 'https://openalex.org/C125287762', 'wikidata': 'https://www.wikidata.org/wiki/Q1758948', 'display_name': 'Absorption (acoustics)', 'level': 2, 'score': 0.5458073}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.53191465}, {'id': 'https://openalex.org/C110121322', 'wikidata': 'https://www.wikidata.org/wiki/Q865811', 'display_name': 'Distribution (mathematics)', 'level': 2, 'score': 0.5266036}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.5003176}, {'id': 'https://openalex.org/C2779220645', 'wikidata': 'https://www.wikidata.org/wiki/Q21099132', 'display_name': 'Alectinib', 'level': 5, 'score': 0.49993753}, {'id': 'https://openalex.org/C168031717', 'wikidata': 'https://www.wikidata.org/wiki/Q1530280', 'display_name': 'Balance (ability)', 'level': 2, 'score': 0.44805762}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4398216}, {'id': 'https://openalex.org/C62231903', 'wikidata': 'https://www.wikidata.org/wiki/Q1057', 'display_name': 'Metabolism', 'level': 2, 'score': 0.42076904}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.28305084}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.27775526}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.1846908}, {'id': 'https://openalex.org/C2779422266', 'wikidata': 'https://www.wikidata.org/wiki/Q5186964', 'display_name': 'Crizotinib', 'level': 4, 'score': 0.13213578}, {'id': 'https://openalex.org/C33923547', 'wikidata': 'https://www.wikidata.org/wiki/Q395', 'display_name': 'Mathematics', 'level': 0, 'score': 0.07981759}, {'id': 'https://openalex.org/C2779634585', 'wikidata': 'https://www.wikidata.org/wiki/Q1334541', 'display_name': 'Pleural effusion', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C134306372', 'wikidata': 'https://www.wikidata.org/wiki/Q7754', 'display_name': 'Mathematical analysis', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C24890656', 'wikidata': 'https://www.wikidata.org/wiki/Q82811', 'display_name': 'Acoustics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C99508421', 'wikidata': 'https://www.wikidata.org/wiki/Q2678675', 'display_name': 'Physical medicine and rehabilitation', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C2776232967', 'wikidata': 'https://www.wikidata.org/wiki/Q6743514', 'display_name': 'Malignant pleural effusion', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D002227', 'descriptor_name': 'Carbazoles', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077548', 'descriptor_name': 'Anaplastic Lymphoma Kinase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001682', 'descriptor_name': 'Biological Availability', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002227', 'descriptor_name': 'Carbazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D002227', 'descriptor_name': 'Carbazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018592', 'descriptor_name': 'Cross-Over Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D064368', 'descriptor_name': 'Healthy Volunteers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020794', 'descriptor_name': 'Receptor Protein-Tyrosine Kinases', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D020794', 'descriptor_name': 'Receptor Protein-Tyrosine Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014018', 'descriptor_name': 'Tissue Distribution', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/00498254.2016.1179821', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48760969', 'display_name': 'Xenobiotica', 'issn_l': '0049-8254', 'issn': ['0049-8254', '1366-5928'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27180975', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.56, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 28, 'referenced_works': ['https://openalex.org/W1515666340', 'https://openalex.org/W152943885', 'https://openalex.org/W1552307519', 'https://openalex.org/W1552410299', 'https://openalex.org/W1834879878', 'https://openalex.org/W1976169212', 'https://openalex.org/W1976648897', 'https://openalex.org/W2004747801', 'https://openalex.org/W2010619956', 'https://openalex.org/W2025489612', 'https://openalex.org/W2044936103', 'https://openalex.org/W2050249255', 'https://openalex.org/W2052016211', 'https://openalex.org/W2055402151', 'https://openalex.org/W2061278019', 'https://openalex.org/W2066417528', 'https://openalex.org/W2091639070', 'https://openalex.org/W2104830962', 'https://openalex.org/W2127354384', 'https://openalex.org/W2134787029', 'https://openalex.org/W2152796502', 'https://openalex.org/W2170437441', 'https://openalex.org/W2174368583', 'https://openalex.org/W2208535430', 'https://openalex.org/W2348313778', 'https://openalex.org/W2511937637', 'https://openalex.org/W2523104533', 'https://openalex.org/W2568709466'], 'related_works': ['https://openalex.org/W4238064147', 'https://openalex.org/W4232445662', 'https://openalex.org/W4231915261', 'https://openalex.org/W3095243115', 'https://openalex.org/W2988298372', 'https://openalex.org/W2941535758', 'https://openalex.org/W2765214248', 'https://openalex.org/W2556417277', 'https://openalex.org/W2325837817', 'https://openalex.org/W2235388618'], 'abstract_inverted_index': {'1.': [0], 'Alectinib': [1, 130], 'is': [2], 'a': [3, 27, 43, 56], 'highly': [4], 'selective,': [5], 'central': [6], 'nervous': [7], 'system-active': [8], 'small': [9], 'molecule': [10], 'anaplastic': [11], 'lymphoma': [12], 'kinase': [13], 'inhibitor.2.': [14], 'The': [15, 77], 'absolute': [16, 78], 'bioavailability,': [17], 'metabolism,': [18], 'excretion': [19, 119, 126, 186], 'and': [20, 55, 98, 124, 131, 164, 170, 185, 196], 'pharmacokinetics': [21], 'of': [22, 38, 49, 63, 80, 93, 108, 146, 153, 172], 'alectinib': [23, 39, 50, 65, 81, 159, 194], 'were': [24, 137], 'studied': [25], 'in': [26, 51, 68, 121, 127, 141, 188, 198], 'two-period': [28], 'single-sequence': [29], 'crossover': [30], 'study.': [31], 'A': [32], '50': [33], 'μg': [34], 'radiolabelled': [35, 64], 'intravenous': [36], 'microdose': [37], 'was': [40, 66, 82, 89, 95, 103, 111, 155], 'co-administered': [41], 'with': [42, 118, 160], 'single': [44, 57], '600': [45, 58], 'mg': [46], 'oral': [47, 61], 'dose': [48, 62, 154], 'the': [52, 69, 99, 138, 180], 'first': [53], 'period,': [54], 'mg/67': [59], 'μCi': [60], 'administered': [67, 109], 'second': [70], 'period': [71], 'to': [72, 167], 'six': [73], 'healthy': [74], 'male': [75], 'subjects.3.': [76], 'bioavailability': [79], 'moderate': [83], 'at': [84], '36.9%.': [85], 'Geometric': [86], 'mean': [87], 'clearance': [88], '34.5': [90], 'L/h,': [91], 'volume': [92], 'distribution': [94], '475': [96], 'L': [97], 'hepatic': [100], 'extraction': [101], 'ratio': [102], 'low': [104], '(0.14).4.': [105], 'Near-complete': [106], 'recovery': [107], 'radioactivity': [110], 'achieved': [112], 'within': [113], '168': [114], 'h': [115], 'post-dose': [116], '(98.2%)': [117], 'predominantly': [120], 'faeces': [122], '(97.8%)': [123], 'negligible': [125], 'urine': [128], '(0.456%).': [129], 'its': [132], 'major': [133], 'active': [134], 'metabolite,': [135], 'M4,': [136, 162], 'main': [139], 'components': [140], 'plasma,': [142], 'accounting': [143], 'for': [144], '76%': [145], 'total': [147], 'plasma': [148], 'radioactivity.': [149], 'In': [150], 'faeces,': [151], '84%': [152], 'excreted': [156], 'as': [157], 'unchanged': [158], 'metabolites': [161], 'M1a/b': [163], 'M6': [165], 'contributing': [166], '5.8%,': [168], '7.2%': [169], '0.2%': [171], 'dose,': [173], 'respectively.5.': [174], 'This': [175], 'novel': [176], 'study': [177], 'design': [178], 'characterised': [179], 'full': [181], 'absorption,': [182], 'distribution,': [183], 'metabolism': [184], 'properties': [187], 'each': [189], 'subject,': [190], 'providing': [191], 'insight': [192], 'into': [193], 'absorption': [195], 'disposition': [197], 'humans.': [199]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2395237281', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 12}, {'year': 2022, 'cited_by_count': 6}, {'year': 2021, 'cited_by_count': 7}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 6}, {'year': 2018, 'cited_by_count': 7}, {'year': 2017, 'cited_by_count': 4}, {'year': 2016, 'cited_by_count': 6}], 'updated_date': '2025-01-12T17:52:54.178032', 'created_date': '2016-06-24'}